Dr Reddys Laboratories (RDY) Operating Expenses (2009 - 2026)

Dr Reddys Laboratories has reported Operating Expenses for 18 years, with the latest figure at $356.6 million in Q2 2026.

• On a quarterly basis, Operating Expenses fell 2.05% year-over-year to $356.6 million in Q2 2026; TTM through Jun 2026 was $153.8 billion, a 114.81% increase from a year earlier, with the FY2026 full-year figure at $1.4 billion, down 99.48% from the prior year.
• Operating Expenses was $356.6 million for Q2 2026 at Dr Reddys Laboratories, down from $78.3 billion in the prior quarter.
• The five-year high for Operating Expenses was $78.3 billion in Q1 2026, with the low at $178.9 million in Q2 2022.
• Average Operating Expenses over 5 years is $12.7 billion, with a median of $345.9 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2025: Operating Expenses plunged 30.91% in 2022, then jumped 21975.83% in 2025.
• Over 5 years, Operating Expenses stood at $288.3 million in 2022, then rose by 3.89% to $299.5 million in 2023, then rose by 19.96% to $359.2 million in 2024, then jumped by 20725.19% to $74.8 billion in 2025, then tumbled by 99.52% to $356.6 million in 2026.
• The last three Operating Expenses figures came in at $356.6 million (Q2 2026), $78.3 billion (Q1 2026), and $74.8 billion (Q4 2025), per Business Quant data.